SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $255,000 | -92.3% | 2,665 | -88.6% | 0.01% | -85.2% |
Q3 2018 | $3,313,000 | -68.7% | 23,454 | -65.3% | 0.09% | -67.9% |
Q2 2018 | $10,589,000 | +2960.4% | 67,648 | +3050.8% | 0.27% | +2390.9% |
Q1 2018 | $346,000 | +68.8% | 2,147 | -25.5% | 0.01% | +10.0% |
Q1 2017 | $205,000 | – | 2,881 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |